NO955351L - Proteininnkapslede, uopplöselige gassmikrosfærer, deres fremstilling og anvendelse som ultralydkontrastmiddel - Google Patents

Proteininnkapslede, uopplöselige gassmikrosfærer, deres fremstilling og anvendelse som ultralydkontrastmiddel

Info

Publication number
NO955351L
NO955351L NO955351A NO955351A NO955351L NO 955351 L NO955351 L NO 955351L NO 955351 A NO955351 A NO 955351A NO 955351 A NO955351 A NO 955351A NO 955351 L NO955351 L NO 955351L
Authority
NO
Norway
Prior art keywords
protein
encapsulated
preparation
contrast agent
insoluble gas
Prior art date
Application number
NO955351A
Other languages
English (en)
Other versions
NO955351D0 (no
Inventor
Karel J Lambert
Sheila Benay Podell
Edward J Jablonski
Carl Hulle
Kenneth Hamilton
Rolf Lohrman
Original Assignee
Molecular Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26775071&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO955351(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Molecular Biosystems Inc filed Critical Molecular Biosystems Inc
Publication of NO955351D0 publication Critical patent/NO955351D0/no
Publication of NO955351L publication Critical patent/NO955351L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)

Abstract

' Mlkrosfærer med omsluttet gass som har forbedret : : trykkreslstens og stabilitet blir fremstilt ved: blanding av en vandig oppløsning av fllmogent protein slik som humant serumalbumln, med en vann-uoppløsellg gass slik som perfluorpropan og utsette blandingen for ultrasonisk eller mekanisk kavlterlng 1 fravær av oksygen 1 et apparat som er lukket fra atmosfæren.
NO955351A 1993-07-02 1995-12-29 Proteininnkapslede, uopplöselige gassmikrosfærer, deres fremstilling og anvendelse som ultralydkontrastmiddel NO955351L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8671793A 1993-07-02 1993-07-02
US18765694A 1994-01-26 1994-01-26
PCT/US1994/007533 WO1995001187A1 (en) 1993-07-02 1994-07-01 Protein encapsulated insoluble gas microspheres and their preparation and use as ultrasonic imaging agents

Publications (2)

Publication Number Publication Date
NO955351D0 NO955351D0 (no) 1995-12-29
NO955351L true NO955351L (no) 1996-02-02

Family

ID=26775071

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955351A NO955351L (no) 1993-07-02 1995-12-29 Proteininnkapslede, uopplöselige gassmikrosfærer, deres fremstilling og anvendelse som ultralydkontrastmiddel

Country Status (20)

Country Link
US (1) US5552133A (no)
EP (2) EP0633030B1 (no)
JP (3) JP2905598B2 (no)
KR (1) KR100218642B1 (no)
CN (1) CN1129910A (no)
AT (1) ATE179334T1 (no)
AU (1) AU683485B2 (no)
BR (1) BR9406993A (no)
CA (1) CA2166459C (no)
CZ (1) CZ350895A3 (no)
DE (2) DE69418101T2 (no)
ES (2) ES2134321T3 (no)
FI (1) FI956312L (no)
HU (1) HUT74827A (no)
IL (1) IL110185A (no)
NO (1) NO955351L (no)
NZ (1) NZ268826A (no)
PL (1) PL312387A1 (no)
TW (1) TW283646B (no)
WO (1) WO1995001187A1 (no)

Families Citing this family (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5656211A (en) 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5773024A (en) 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5469854A (en) 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US6146657A (en) 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5305757A (en) 1989-12-22 1994-04-26 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5776429A (en) 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
IN172208B (no) 1990-04-02 1993-05-01 Sint Sa
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
US20040208826A1 (en) * 1990-04-02 2004-10-21 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US6989141B2 (en) * 1990-05-18 2006-01-24 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US7083778B2 (en) * 1991-05-03 2006-08-01 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
USRE39146E1 (en) 1990-04-02 2006-06-27 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US20010024638A1 (en) * 1992-11-02 2001-09-27 Michel Schneider Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US6613306B1 (en) 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
US20030194376A1 (en) * 1990-05-18 2003-10-16 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5205290A (en) * 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US6875420B1 (en) 1991-09-17 2005-04-05 Amersham Health As Method of ultrasound imaging
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
IL104084A (en) 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
HUT72323A (en) * 1993-01-25 1996-04-29 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5701899A (en) * 1993-05-12 1997-12-30 The Board Of Regents Of The University Of Nebraska Perfluorobutane ultrasound contrast agent and methods for its manufacture and use
US5695740A (en) * 1993-05-12 1997-12-09 The Board Of Regents Of The University Of Nebraska Perfluorocarbon ultrasound contrast agent comprising microbubbles containing a filmogenic protein and a saccharide
EP0711179B2 (en) 1993-07-30 2010-09-01 IMCOR Pharmaceutical Co. Stabilized microbubble compositions for ultrasound
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
ATE234638T1 (de) * 1993-12-15 2003-04-15 Bracco Research Sa Gas-mischungen verwendbar als ultraschallkontrastmittel
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
US5736121A (en) 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
US5965109A (en) * 1994-08-02 1999-10-12 Molecular Biosystems, Inc. Process for making insoluble gas-filled microspheres containing a liquid hydrophobic barrier
US5730955A (en) * 1994-08-02 1998-03-24 Molecular Biosystems, Inc. Process for making gas-filled microspheres containing a liquid hydrophobic barrier
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US5997898A (en) 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US5897851A (en) * 1995-06-07 1999-04-27 Sonus Pharmaceuticals, Inc. Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US5674469A (en) * 1995-06-07 1997-10-07 Molecular Biosystems, Inc. Gas-exchange method of making gas-filled microspheres
US5648098A (en) * 1995-10-17 1997-07-15 The Board Of Regents Of The University Of Nebraska Thrombolytic agents and methods of treatment for thrombosis
US6245747B1 (en) 1996-03-12 2001-06-12 The Board Of Regents Of The University Of Nebraska Targeted site specific antisense oligodeoxynucleotide delivery method
CA2252617A1 (en) 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5976501A (en) * 1996-06-07 1999-11-02 Molecular Biosystems, Inc. Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion
CN1042700C (zh) * 1996-06-25 1999-03-31 谢峰 含有全氟化碳或六氟化硫的右旋糖酐白蛋白声学造影剂及其制作方法
US5849727A (en) * 1996-06-28 1998-12-15 Board Of Regents Of The University Of Nebraska Compositions and methods for altering the biodistribution of biological agents
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DE69718519T2 (de) 1996-09-11 2003-11-06 Imarx Pharmaceutical Corp., Tucson Verbesserte verfahren zur diagnostischen bilderzeugung unter verwendung eines kontrastmittels und eines vasodilators
US6083484A (en) * 1996-10-17 2000-07-04 Molecular Biosystems, Inc. Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
AU7702798A (en) 1997-05-30 1998-12-30 Alliance Pharmaceutical Corporation Methods and apparatus for monitoring and quantifying the movement of fluid
JP4841710B2 (ja) 1997-07-04 2011-12-21 ジーイー・ヘルスケア・アクスイェ・セルスカプ 小気胞状薬剤製品から予め選んだサイズの小気胞を選ぶ方法
JP4808842B2 (ja) * 1997-08-18 2011-11-02 ジーイー・ヘルスケア・アクスイェ・セルスカプ 小胞の調製方法
GB9717476D0 (en) * 1997-08-18 1997-10-22 Nycomed Imaging As Process
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6386751B1 (en) 1997-10-24 2002-05-14 Diffusion Dynamics, Inc. Diffuser/emulsifier
US6702949B2 (en) 1997-10-24 2004-03-09 Microdiffusion, Inc. Diffuser/emulsifier for aquaculture applications
US7128278B2 (en) 1997-10-24 2006-10-31 Microdiffusion, Inc. System and method for irritating with aerated water
US7654728B2 (en) * 1997-10-24 2010-02-02 Revalesio Corporation System and method for therapeutic application of dissolved oxygen
US20110075507A1 (en) * 1997-10-24 2011-03-31 Revalesio Corporation Diffuser/emulsifier
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US20010021372A1 (en) * 1998-08-18 2001-09-13 Tore Omtveit Apparatus having partially gold-plated surface
DK1139799T3 (da) * 1998-12-23 2003-10-20 Unilever Nv Hældbare vand- og olieholdige emulsioner, der indeholder gasbobler
US6444192B1 (en) 1999-02-05 2002-09-03 The Regents Of The University Of California Diagnostic imaging of lymph structures
US20050150618A1 (en) * 2000-05-17 2005-07-14 Bijan Kazem Methods of processing lignocellulosic pulp with cavitation
US6627784B2 (en) 2000-05-17 2003-09-30 Hydro Dynamics, Inc. Highly efficient method of mixing dissimilar fluids using mechanically induced cavitation
US7109167B2 (en) 2000-06-02 2006-09-19 Bracco International B.V. Compounds for targeting endothelial cells, compositions containing the same and methods for their use
AU2002253454A1 (en) 2001-04-06 2002-10-21 Bracco Research S.A. Method for improved measurement of local physical parameters in afluid-filled cavity
US7087212B2 (en) 2001-08-17 2006-08-08 Mallinckrodt, Inc Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
AU2003213730A1 (en) 2002-03-01 2003-09-16 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US20040126400A1 (en) * 2002-05-03 2004-07-01 Iversen Patrick L. Delivery of therapeutic compounds via microparticles or microbubbles
US6823820B2 (en) 2002-12-03 2004-11-30 Christian Helmut Thoma Apparatus for heating fluids
EP2284180B1 (en) 2003-03-03 2015-09-09 Dyax Corp. Uses of peptides that specifically bind HGF receptor (cMET)
CA2526333C (en) * 2003-05-19 2011-12-06 Hydro Dynamics, Inc. Method and apparatus for conducting a chemical reaction in the presence of cavitation and an electrical current
US6910448B2 (en) 2003-07-07 2005-06-28 Christian Thoma Apparatus and method for heating fluids
WO2005021050A1 (en) * 2003-08-22 2005-03-10 Hydro Dynamics, Inc. Method and apparatus for irradiating fluids
US8076117B2 (en) * 2004-03-18 2011-12-13 Mayo Foundation For Medical Education And Research Microbial biofilm removal methods and systems
US7316501B2 (en) * 2004-05-20 2008-01-08 Christian Thoma Apparatus and method for mixing dissimilar fluids
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US8883865B2 (en) 2006-09-05 2014-11-11 Cerion Technology, Inc. Cerium-containing nanoparticles
WO2008030810A2 (en) 2006-09-05 2008-03-13 Cerion Technologies, Inc. Ceramic high temperature lubricity agent
US10435639B2 (en) 2006-09-05 2019-10-08 Cerion, Llc Fuel additive containing lattice engineered cerium dioxide nanoparticles
WO2008115290A2 (en) 2006-10-25 2008-09-25 Revalesio Corporation Methods of wound care and treatment
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
EP2086668B1 (en) 2006-10-25 2016-11-16 Revalesio Corporation Mixing device and method
US8609148B2 (en) 2006-10-25 2013-12-17 Revalesio Corporation Methods of therapeutic treatment of eyes
AU2007308840C1 (en) 2006-10-25 2014-09-25 Revalesio Corporation Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8465642B2 (en) * 2007-05-04 2013-06-18 Hydro Dynamics, Inc. Method and apparatus for separating impurities from a liquid stream by electrically generated gas bubbles
US20090036856A1 (en) * 2007-07-31 2009-02-05 Kimberly-Clark Worldwide, Inc. Triggerable self-generating liquid foam barrier/interceptor
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US8430968B2 (en) 2008-01-22 2013-04-30 Hydro Dynamics, Inc. Method of extracting starches and sugar from biological material using controlled cavitation
BRPI0911757A2 (pt) 2008-05-01 2013-09-17 Revalesio Corp composiÇÕes e mÉtodos para tratar distérbios digestivos.
WO2010067059A1 (en) 2008-12-12 2010-06-17 The University Of Birmingham Low fat food containing gas bubbles
US8846063B2 (en) * 2008-12-16 2014-09-30 Kimberly-Clark Worldwide, Inc. Personal care composition containing a volatile and a terpene alcohol
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
BR112012015200B1 (pt) 2009-12-22 2021-07-20 Evonik Corporation Processo para preparar micropartículas, e, conjunto de cabeça de trabalho para um misturador através de fluxo não estático
BR112012028540A2 (pt) 2010-05-07 2016-07-26 Revalesio Corp composições e métodos para melhorar desempenho fisiológico e tempo de recuperação
CN101926821B (zh) * 2010-07-12 2012-01-25 四川大学华西医院 一种靶向释放微量元素的药物组合物及制备方法和应用
CN102302507B (zh) * 2010-07-12 2014-02-05 四川大学华西医院 定向控释微量元素的药物组合物及制备方法和应用
JP2013533320A (ja) 2010-08-12 2013-08-22 レバレジオ コーポレイション タウオパチーを治療するための組成物および方法
CZ303992B6 (cs) * 2010-11-04 2013-08-07 Student Science, S.R.O. Nanovlákenné nosice s fotoafinne vázanými mikrosférami a zpusob jejich výroby
US20140072502A1 (en) * 2011-05-27 2014-03-13 M. Technique Co., Ltd. Fine bubble generating apparatus, method for generating fine bubbles, and method for gas-liquid reaction using same
KR20120140290A (ko) * 2011-06-21 2012-12-31 주식회사 퍼시픽시스템 기능성 물질의 전달을 촉진하는 기포 제조 방법 및 이를 이용하는 기능성 물질 전달 장치
MX374926B (es) * 2012-04-30 2025-03-06 Ge Healthcare As Metodo para llenar un contenedor con una composicion espumable.
ES2571481T3 (es) * 2012-06-26 2016-05-25 Ge Healthcare As Preparación de una composición que comprende microburbujas de gas
WO2015058037A1 (en) 2013-10-17 2015-04-23 Cerion, Llc Malic acid stabilized nanoceria particles
CN105233308B (zh) * 2015-11-02 2018-10-30 中国科学院深圳先进技术研究院 一种用于hifu的超声造影剂及其制备方法与应用
US11007287B2 (en) 2016-02-25 2021-05-18 King Abdullah University Of Science And Technology Acoustically excited encapsulated microbubbles and mitigation of biofouling
WO2018071551A1 (en) 2016-10-11 2018-04-19 Thomas Jefferson University Non-invasive method for pressure measurement
CN107519502B (zh) * 2017-08-20 2019-01-15 湖南康润药业有限公司 超声造影微泡的制备方法及超声造影微泡
CN115970600B (zh) * 2022-12-17 2025-12-02 湖南康润药业股份有限公司 一种含气微球注射液自动制备机
CN116983439B (zh) * 2023-08-03 2025-10-31 上海瑞凝生物科技有限公司 一种含有超声显影气泡微球的医用水凝胶及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572203A (en) * 1983-01-27 1986-02-25 Feinstein Steven B Contact agents for ultrasonic imaging
US4718433A (en) * 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
IE61591B1 (en) * 1987-12-29 1994-11-16 Molecular Biosystems Inc Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production
US4957656A (en) * 1988-09-14 1990-09-18 Molecular Biosystems, Inc. Continuous sonication method for preparing protein encapsulated microbubbles
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
EP0504340B1 (en) * 1990-10-05 1995-06-21 BRACCO International B.V. Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
HU218018B (hu) * 1991-09-17 2000-05-28 Sonus Pharmaceuticals Inc. Gázos ultrahang-kontrasztanyag és eljárás ultrahang kontrasztanyaghoz megfelelő gázok kiválasztására
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them

Also Published As

Publication number Publication date
BR9406993A (pt) 1996-09-10
NO955351D0 (no) 1995-12-29
JPH11139995A (ja) 1999-05-25
HUT74827A (en) 1997-02-28
JPH08509002A (ja) 1996-09-24
HU9503977D0 (en) 1996-03-28
US5552133A (en) 1996-09-03
EP0885615A1 (en) 1998-12-23
FI956312A0 (fi) 1995-12-29
NZ268826A (en) 1996-11-26
CA2166459C (en) 2000-03-28
FI956312A7 (fi) 1996-01-17
EP0633030A1 (en) 1995-01-11
JP3809368B2 (ja) 2006-08-16
CN1129910A (zh) 1996-08-28
PL312387A1 (en) 1996-04-15
WO1995001187A1 (en) 1995-01-12
JP2905598B2 (ja) 1999-06-14
ATE179334T1 (de) 1999-05-15
EP0633030B1 (en) 1999-04-28
DE69432370D1 (de) 2003-04-30
JP2002167338A (ja) 2002-06-11
DE69418101D1 (de) 1999-06-02
IL110185A0 (en) 1994-10-21
KR960703624A (ko) 1996-08-31
ES2134321T3 (es) 1999-10-01
JP3285544B2 (ja) 2002-05-27
EP0885615B1 (en) 2003-03-26
KR100218642B1 (ko) 1999-09-01
FI956312L (fi) 1996-01-17
ES2195247T3 (es) 2003-12-01
DE69432370T2 (de) 2004-02-19
TW283646B (no) 1996-08-21
DE69418101T2 (de) 1999-11-11
CZ350895A3 (en) 1996-10-16
IL110185A (en) 1999-05-09
CA2166459A1 (en) 1995-01-12
AU7218494A (en) 1995-01-24
AU683485B2 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
NO955351D0 (no) Proteininnkapslede, uopplöselige gassmikrosfærer, deres fremstilling og anvendelse som ultralydkontrastmiddel
PT89835A (pt) Processo para a preparacao de uma formulacao de relaxina humana
NO922203L (no) Fremgangsmaate for fremstilling av stabile suspensjoner med hule gassfylte mikrosfaerer som er velegnet for ultralydekkografi
MY102472A (en) Preparation of funtional human urokinase proteins.
ES469328A1 (es) Procedimiento para el enriquecimiento de una nueva glucopre-teina.
Short Jr et al. Expression of antiviral activity and induction of 2′, 5′-oligoadenylate synthetase by conceptus secretory proteins enriched in bovine trophoblast protein-1
DK0424028T3 (da) S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
ES2055684T3 (es) Un metodo para preparar un agente para el tratamiento de la leucopenia.
DE69836499T2 (de) Virus mit membranmutationen für ein witsspektrum und deren verwendung als vakzinsubstrat
ATE130198T1 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
DK208987D0 (da) Polypeptider og antistoffer, som er karakteristiske for papillomvirus, og deres anvendelse ved diagnostiske metoder og i vacciner
Levy et al. Prophylactic control of simian hemorrhagic fever in monkeys by an interferon inducer, polyriboinosinic-polyribocytidylic acid-poly-L-lysine
PT712926E (pt) Virus da doenca pancreatica do peixe
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
NO870123L (no) Mastittvaksine.
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
Mckillop Effects of phenobarbitone and β-naphthoflavone on hepatic microsomal drug metabolising enzymes of the male beagle dog
NO912942L (no) Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.
NO943699L (no) Fremgangsmåte for kontinuerlig fremstilling av en fast matvarematriks
NO881111D0 (no) Fremgangsmaate til isolering av basalmembranproteiner fra menneskelige og dyriske vev.
IL86638A0 (en) (2-cyano-2-oximinoacetyl)-amino acid derivatives,their preparation and their use as pesticides
Slabý Morphogenesis of the nasal capsule, the nasal epithelial tube and the organ of Jacobson in Sauropsida. I. Introduction and morphogenesis of the nasal apparatus in members of the families Lacertidae and Scincidae
Bolin et al. Use of guinea pig eye in study of intraocular infections produced by mumps virus.
Kousvelari et al. Dolichyl phosphate supplementation increases N-linked protein glycosylation in rat parotid acinar cells without increasing glycoprotein secretion
Korner et al. Effects of ionizing irradiation on endothelial cell transglutaminase